COYA THERAPEUTICS INC (COYA) Stock Income Statement
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.55M | 6.00M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 20.69M | 13.36M | 9.81M | 4.87M | 690.00K | |||
| Research and Development | 11.54M | 5.50M | 4.94M | 2.54M | 250.00K | |||
| Selling, General, and Administrative Expenses | 9.13M | 7.83M | 4.85M | 2.31M | 450.00K | |||
| Operating Income | -11.14M | -7.36M | -9.81M | -4.87M | -690.00K | |||
| Interest Income/Expense | N/A | N/A | N/A | 0.00 | -40.00K | |||
| Other Income/Expense | 1.38M | 639.40K | -2.43M | -20.00K | 0.00 | |||
| Non Recurring Items | -218.20K | -543.20K | N/A | N/A | N/A | |||
| Income Before Taxes | -9.98M | -7.26M | -12.24M | -4.89M | -730.00K | |||
| Income Tax | N/A | 723.90K | N/A | N/A | N/A | |||
| Net Income | -10.70M | -7.99M | -12.24M | -4.89M | -730.00K | |||
| EBITDA | -11.11M | -7.33M | -9.78M | -4.85M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.69 | -0.79 | -1.23 | -0.51 | -0.08 | |||
| Non GAAP EPS | -0.52 | -0.79 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -111.98% | -133.08% | N/A | N/A | N/A | |||
| Operating Profit Margin | -116.55% | -122.63% | N/A | N/A | N/A | |||
All data in USD